Neuralink Prepares Human Trials for Thought-to-Text Interface
In a groundbreaking move towards a future where technology and neural pathways seamlessly integrate, Neuralink is paving the way with its upcoming US clinical trial. This trial, set to commence in October, will explore the possibilities of translating thoughts directly into text. With the approval of the FDA, this remarkable advance aims to transform how people with speech impairments communicate, promising a new era of “thought-to-text” capabilities.